▽epratuzumab - PubMed - NCBI ●01/09 09:57 Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases.Steinfeld SD, Youinou P. Steinfeld SD, et al. Expert Opin Biol Ther. 2006 Sep;6(9):943-9. doi: 10.1517/14712598.6.9.943. Expert Opin Biol Ther. 2006. PMID: 16918261 Review.Selective modulation of B cells has been recently achieved using a humanised monoclonal antibody against the B cell surface marker CD22. This antibody (epratuzu
▽pracinostat - PubMed - NCBI ●01/09 07:43 Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.Chen J, Li N, Liu B, Ling J, Yang W, Pang X, Li T. Chen J, et al. Life Sci. 2020 May 1;248:117469. doi: 10.1016/j.lfs.2020.117469. Epub 2020 Feb 25. Life Sci. 2020. PMID: 32109485The novel histone deacetylase inhibitor pracinostat suppresses the
▽Kyowa Hakko Kirin Co., Ltd. ●01/09 06:24 Integrated Report 2023We strive to contribute to the health and well-being of people aroundthe world by creating new value through the pursuit ofadvances in life sciences and technologies.See more
